Meeting
2016 Gastrointestinal Cancers Symposium
A phase I trial with cohort expansion of BYL719 in combination with gemcitabine and nab-paclitaxel in locally advanced and metastatic pancreatic cancer.
Authors
Heloisa P. Soares
Moffitt Cancer Center, Tampa, FL
Heloisa P. Soares , Danny Nguyen , Gregory M. Springett , Richard D. Kim , Irene Williams-Elson , Kara Miller , Nishi Kothari , Amit Mahipal
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Trials in Progress Poster Session
Session Title
Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Translational Research
Clinical Trial Registration Number
NCT02155088
Citation
J Clin Oncol 34, 2016 (suppl 4S; abstr TPS467)
DOI
10.1200/jco.2016.34.4_suppl.tps467
Abstract #
TPS467
Poster Bd #
N17
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
Final report: A phase I trial of BYL719 in combination with gemcitabine and nab-paclitaxel in locally advanced and metastatic pancreatic cancer.
First Author: Heloisa P. Soares
Poster
2018 ASCO Annual Meeting
A phase I study of AL101, a pan-NOTCH inhibitor, in patients (pts) with locally advanced or metastatic solid tumors.
First Author: Anthony B. El-Khoueiry
Poster
2016 ASCO Annual Meeting
Evofosfamide combined with gemcitabine/nab-paclitaxel in patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma (PAC): Results of a phase I trial.
First Author: Mitesh J. Borad
Poster
2014 ASCO Annual Meeting
Phase I study of BYL719 and trastuzumab-MCC-DM1 (T-DM1) in HER2-positive metastatic breast cancer (MBC) patients with progression on trastuzumab and taxane-based therapy.
First Author: Sarika Jain